LifeScan, Inc.
1000 Gibraltar Drive
Milpitas
California
95035
United States
Tel: 408-263-9618
Website: http://www.LifeScanCareers.com/
About LifeScan, Inc.
LifeScan, Inc., a member of the Johnson & Johnson Family of Companies, is a global leader in blood glucose monitoring systems for home and hospital use. LifeScan has been committed to improving the quality of life for people with diabetes for over 20 years. Our small-company environment and big-company impact fosters an innovative culture in which employees play an important role in helping to create a world without limits for people with diabetes. The impact is already far-reaching: Every day, around the world, more than thee million people depend on our OneTouch® brand of blood glucose monitoring systems to help create a healthier lifestyle. And, as a member of the Johnson & Johnson Family of Companies, employees benefit from the stature, resources, and broad career development opportunities available with a global leader in pharmaceutical, medical devices, and consumer health care products.
LifeScan is headquartered in Milpitas, CA, and employs over 2,500 people around the world. We offer a full range of comprehensive benefits, including adoption assistance, educational assistance, on-campus fitness center and employee services, as well as discount purchase programs.
LifeScan is an equal opportunity employer committed to diversity. We invite all interested potential candidates to bid on positions of interest by visiting http://www.LifeScanCareers.com/. EOE M/F/D/V.
47 articles about LifeScan, Inc.
-
Study Results Published in Journal of Diabetes Science and Technology Show Sustained Clinically Significant Improvements in Glycemic Control in Over 144,000 People with Diabetes Using a Smart Blood Glucose Meter and Mobile App
1/31/2023
LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology has published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes – one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
-
New Study Will Examine Additional Health and Economic Benefits for People with Type 2 Diabetes When Personalized Wellness Technologies Are Paired with a Smart Blood Glucose Ecosystem
5/18/2022
LifeScan, a world leader in blood glucose monitoring, today announced recruitment for a new study that will evaluate the clinical and economic value of using the digital health subscriptions offered through OneTouch® Solutions for people with type 2 diabetes.
-
New Studies Demonstrate Clinical Benefits of Patient- and Provider-Supportive Technology in Diabetes Management
4/27/2022
LifeScan, a world leader in blood glucose monitoring, announced today the presentation of three studies showing the value of app-based technology in improving diabetes management.
-
OneTouch Verio Flex® Tops the Forbes Health Best Standard Glucose Meters of 2022 List, Just Announced, Highlighting the Meter's ColorSure® Technology
3/2/2022
LifeScan, a world leader in blood glucose monitoring, announced that its OneTouch Verio Flex®, the blood glucose meter that takes the guesswork out of your numbers so you can get on with life, was just rated Best Standard Glucose Meters Of 2022 by Forbes Health.
-
LifeScan Launches OneTouch® Amazon Storefront, Offers Consumers Access to Authentic OneTouch Diabetes Testing Supplies
9/29/2020
LifeScan , a world leader in blood glucose monitoring and maker of the iconic OneTouch® brand, today announced the launch of its OneTouch Amazon storefront for people managing Type 1 and Type 2 diab
-
Real-World Study Shows OneTouch Reveal® Plus Digital Coach Drives Positive Health Outcomes
8/13/2020
24/7 digital coaching tool impacted self-care behaviors, ER visits for people with Type 2 diabetes, and healthcare costs for health plan
-
LifeScan Announces OneTouch Verio Reflect® Meter U.S. Launch
6/11/2020
Latest innovation helps people with diabetes easily enable telehealth connectivity by linking directly into Apple Health® for effortless sharing with telehealth platforms like Teledoc and Doctor on Demand. [11-June-2020] MALVERN, Pa. , June 11, 2020 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch ® brand, today an
-
LifeScan and Noom to Launch Digital Diabetes and Weight Loss Management Pilot Program
5/12/2020
Pilot will combine LifeScan's diabetes management experience with Noom's disruptive AI-driven behavioral health technology
-
LifeScan Names Ty Lee Head of Marketing
5/20/2019
Former J&J executive returns to his diabetes device roots to help drive patient-centered innovation, growth, and company expansion
-
OneTouch® Blood Glucose Monitoring System Accuracy Proven in New Long-Term Study
2/8/2019
Research demonstrates clinical accuracy of OneTouch Select Plus® platform, and demonstrates the value of a continuous and systematic testing program to verify product performance for as long as it has been available to patients
-
LifeScan Unveils New Name and Branding for the LifeScan Diabetes Institute
11/7/2018
Previously the Johnson & Johnson Diabetes Institute; Remains Committed to Transforming Diabetes Care through World-Class Experiential Learning
-
Newest Release of OneTouch Reveal® Mobile App Provides Even More Insight to Support Diabetes Management
10/30/2018
One of the top global diabetes apps now spots recurring high or low patterns and automatically notifies users so they can take action to avoid them in the future
-
Lifescan Announces Future Innovation at EASD: The OneTouch Verio Reflect™ Blood Glucose Meter featuring Blood Sugar Mentor™
10/4/2018
LifeScan, Inc., a world leader in blood glucose monitoring, revealed its latest innovation—the OneTouch Verio Reflect™ blood glucose meter—as part of a symposium on the future of connected self-monitoring of blood glucose at the European Association for the Study of Diabetes (EASD) 2018 annual meeting today.
-
While the biopharma industry awaits news of an acquisition of Shire by Takeda Pharmaceuticals, it’s a good time to take a look back at the bigger deals so far this year.
-
Platinum Equity submitted a binding offer to Johnson & Johnson to buy LifeScan for $2.1 billion.
-
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
3/16/2018
LifeScan, Inc. is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion.
-
LifeScan's OneTouch Blood Sugar Monitoring System Shown to Exceed Accuracy Standard and Improve Glycemic Control in Two New Studies
10/25/2017
New research published in two leading diabetes journals demonstrated accuracy and reliability of the OneTouch Verio Flex blood glucose monitoring (BGM) system, and when the system was used with the OneTouch Reveal mobile app, it was associated with significant improvements in glycemic control.
-
Qualcomm, Johnson & Johnson's LifeScan Ink Diabetes Web App Pact
6/12/2017
-
Johnson & Johnson's LifeScan Settles Antitrust Lawsuit With UniStrip Tech
5/5/2017
-
LifeScan to Lay Off Up to 80 Employees in Scotland
1/25/2017